change from semaglutide to tirzepatide Switching Tirzepatide: Is It a Good Idea? Switching GLP-1 Agonists for MAXIMUM

Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ: The GH/IGF-1 axis in ageing and longevity

The weight is melting away

The reasons HFpEF is on the rise are multifactorial and include improvement in diagnosis as well as increases in the risk factors for cardiometabolic disease

In regards to arthritis, research suggests that BPC-157 may be useful in reducing joint pain and stiffness as well as improving physical function in patients with rheumatoid arthritis

Compounded semaglutide produced by licensed 503A compounding pharmacies maintains consistent supply because multiple facilities can prepare formulations simultaneously

In: Current Therapies in Thoracic and Cardiovascular Surgery